Categories
Change Password!
Reset Password!
Google the pain
Test content
Novel Tofacitinib Generics: Pioneering 50% csDMARD...
Tofacitinib generics offer a practical solution for patients with axial spondyloarthritis (axSpA) by reducing the need for conventional synthetic disease-modify...
Severe illness from COVID-19 increases susceptibil...
According to a trial, severe COVID-19 disease is linked to higher levels of the tumour necrosis factor-alpha (TNF-α), interleukin (IL)-1, IL-6, and pro-in...
Zoledronic acid reduces blood lipid levels in post...
In postmenopausal females with lipid disorders and osteoporosis, treatment with zoledronic acid combined with atorvastatin or zoledronic acid alone considerably...
First COVID-19 treatment received FDA approval
On 22 October 2020, the United States Food and Drug Administration (USFDA) granted its approval to remdesivir (antiviral drug) for use in adult and pediatric...
Sublingual Cyclobenzaprine (TNX-102 SL) emerges as...
A phase 3, double-blind, randomized, placebo-controlled trial (RELIEF) illustrated that administration of TNX-102 SL (sublingual [SL] formulation of Cyclobenzap...
Dexamethasone found to reduce pain due to periapic...
A study published in “The Journal of Emergency Medicine” depicted that in patients with dental periapical abscess pain, single-dose dexamethasone as an adjunc...
Consider nimesulide as a therapeutic adjuvant to r...
A commentary published in “SLAS Discovery” recommended that nimesulide should be considered for inclusion in the list of drugs to be tested for identifying t...
Use of proton pump inhibitors do not increase risk...
A recent research in the Gastroenterology journal fortified the safety of appropriate usage of proton pump inhibitors therapy during COVID-19. As found, the u...
Virtual reality system is now FDA approved for low...
According to the press release of Food and Drug Administration (FDA) on November 16, 2021, the prescription-use immersive virtual reality (VR) system has bee...
